HighVista Strategies’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-147,233
| Closed | -$2.06M | – | 166 |
|
|
2024
Q3 | $2.06M | Sell |
147,233
-72,183
| -33% | -$1.01M | 0.71% | 43 |
|
|
2024
Q2 | $1.8M | Hold |
219,416
| – | – | 0.66% | 47 |
|
|
2024
Q1 | $1.69M | Hold |
219,416
| – | – | 0.6% | 57 |
|
|
2023
Q4 | $1.97M | Buy |
219,416
+97,016
| +79% | +$872K | 0.72% | 46 |
|
|
2023
Q3 | $1.09M | Buy |
122,400
+97,003
| +382% | +$867K | 0.51% | 55 |
|
|
2023
Q2 | $390K | Sell |
25,397
-96,437
| -79% | -$1.48M | 0.18% | 127 |
|
|
2023
Q1 | $2.74M | Hold |
121,834
| – | – | 2.23% | 11 |
|
|
2022
Q4 | $2.56M | Buy |
121,834
+11,136
| +10% | +$234K | 1.52% | 20 |
|
|
2022
Q3 | $2.73M | Buy |
110,698
+6,548
| +6% | +$161K | 1.56% | 23 |
|
|
2022
Q2 | $2.52M | Buy |
104,150
+71,649
| +220% | +$1.74M | 1.52% | 21 |
|
|
2022
Q1 | $838K | Sell |
32,501
-21,602
| -40% | -$557K | 0.53% | 54 |
|
|
2021
Q4 | $1.68M | Sell |
54,103
-2,591
| -5% | -$80.4K | 1.34% | 17 |
|
|
2021
Q3 | $1.38M | Buy |
56,694
+3,196
| +6% | +$77.5K | 0.91% | 24 |
|
|
2021
Q2 | $781K | Buy |
53,498
+28,876
| +117% | +$422K | 0.55% | 54 |
|
|
2021
Q1 | $615K | Buy |
+24,622
| New | +$615K | 0.46% | 55 |
|